Cover Image

Prisoners should not be left behind in HCV research and policies

With a worldwide prevalence of 15.4%, hepatitis C virus (HCV) has been estimated to be the most prevalent major infectious disease in prisons. The exceptionally high prevalence of HCV in prisons is attributable to common risk behaviors including sharing contaminated tattooing equipment and drug para...

Full description

Saved in:
Bibliographic Details
Main Authors: Moazen, Babak (Author) , Stöver, Heino (Author) , Dolan, Kate (Author) , Jahn, Albrecht (Author) , Neuhann, Florian (Author)
Format: Article (Journal)
Language:English
Published: 24 May 2020
In: Harm reduction journal
Year: 2020, Volume: 17, Pages: 1-2
ISSN:1477-7517
DOI:10.1186/s12954-020-00379-y
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12954-020-00379-y
Verlag, lizenzpflichtig, Volltext: https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-020-00379-y
Get full text
Author Notes:Babak Moazen, Heino Stöver, Kate Dolan, Albrecht Jahn and Florian Neuhann
Description
Summary:With a worldwide prevalence of 15.4%, hepatitis C virus (HCV) has been estimated to be the most prevalent major infectious disease in prisons. The exceptionally high prevalence of HCV in prisons is attributable to common risk behaviors including sharing contaminated tattooing equipment and drug paraphernalia, as well as lack of HCV control interventions including needle and syringe programs. Despite the importance of attention to prisoners as a highly at-risk population to acquire and transmit HCV, the number of HCV research and policy documents ignoring prisoners is increasing. Highlighting this issue, the present manuscript discusses how excluding prisoners from HCV-related research and policies will jeopardize the global HCV elimination goals set forth by the global community.
Item Description:Gesehen am 31.03.2021
Physical Description:Online Resource
ISSN:1477-7517
DOI:10.1186/s12954-020-00379-y

Similar Items